Chronic Myeloid Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Not yet recruiting
  • Chronic Myeloid Leukemia
  • (no location specified)
2022-03-30
Mar 30, 2022
S
Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies
Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2022-04-04
Apr 4, 2022
S
Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
Recruiting
  • Chronic Myeloid Leukemia
  • Aalborg, Denmark
  • +17 more
2022-04-04
Apr 4, 2022
I
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
Recruiting
  • Chronic Myeloid Leukemia
  • +3 more
    • Antwerpen, Belgium
    • +18 more
    2022-03-31
    Mar 31, 2022
    H
    Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Cairo, Egypt
    • +1 more
    2022-03-16
    Mar 16, 2022
    F
    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
    Recruiting
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2022-03-16
    Mar 16, 2022
    N
    A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia Treated With Nilotinib
    Recruiting
    • Chronic Myeloid Leukemia
    • Bari, BA, Italy
    • +28 more
    2022-03-30
    Mar 30, 2022
    W
    Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy - 2021
    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • New York, New York
      Weill Cornell Medical College
    2022-03-24
    Mar 24, 2022
    P
    International Chronic Myeloid Leukemia Pediatric Study
    Recruiting
    • Chronic Myeloid Leukemia
      • Buenos Aires, Argentina
      • +20 more
      2022-03-22
      Mar 22, 2022
      K
      KRT-232 and TKI Study in Chronic Myeloid Leukemia
      Recruiting
      • Chronic Myeloid Leukemia
      • Birmingham, Alabama
      • +25 more
      2022-03-04
      Mar 4, 2022
      N
      Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
      Active, not recruiting
      Has Results
      • Chronic Myeloid Leukemia
      • Los Angeles, California
      • +61 more
      2022-03-17
      Mar 17, 2022
      G
      Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT - 2012
      Completed
      • Acute Myeloid Leukemia
      • +3 more
        • (no location specified)
        2022-03-16
        Mar 16, 2022
        S
        Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
        Recruiting
        • Dasatinib
        • +2 more
        • Shenzhen, Guangdong, China
          Xin Du
        2022-03-15
        Mar 15, 2022
        U
        Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • EAGD T-cell infusion (Phase I)
        • EAGD T-cell infusion (Expansion)
        • Westwood, Kansas
          University of Kansas Cancer Center
        2022-03-15
        Mar 15, 2022
        E
        Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
        No longer available
        • Chronic Myeloid Leukemia
        • +2 more
        • G-CSF mobilized CD34+ selected cells for transplantation
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        2022-02-28
        Feb 28, 2022
        N
        IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT - 2021
        Terminated
        • Acute Myeloid Leukemia
        • +3 more
        • Indianapolis, Indiana
          Indiana University Melvin & Bren Simon Cancer Center
        2022-02-22
        Feb 22, 2022
        A
        MargheRITA (Remote Intelligence for Therapeutic Adherence)
        Not yet recruiting
        • Multiple Myeloma
        • +13 more
        • RITA (App)
        • (no location specified)
        2022-02-24
        Feb 24, 2022
        C
        Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia
        Recruiting
        • Chronic Myeloid Leukemia
        • Pharmaceutical intervention
        • Saint-Étienne, France
          CHU de Saint-Etienne
        2022-02-24
        Feb 24, 2022
        U
        A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
        Recruiting
        • Myeloproliferative Neoplasm
        • +2 more
        • Online Mindfulness Meditation
        • Internet-Based Webinars
        • San Francisco, California
          University of California San Francisco
        2022-02-22
        Feb 22, 2022
        M
        Off-the-shelf NK Cells + SCT for Myeloid Malignancies
        Not yet recruiting
        • Myeloid Malignancies
        • +3 more
        • Houston, Texas
          M D Anderson Caner Center
        2022-02-08
        Feb 8, 2022
        B
        TCR Alpha/Beta and CD19 TCD in HCT for Patients With Hematological Malignancies and Nonmalignant Disorders
        Not yet recruiting
        • Acute Lymphoblastic Leukemia in Remission
        • +10 more
        • CliniMACS
        • Houston, Texas
        • +1 more
        2022-02-02
        Feb 2, 2022
        A
        Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
        Recruiting
        • Leukemia, Myeloid, Chronic
        • +4 more
        • Birmingham, Alabama
        • +7 more
        2022-02-10
        Feb 10, 2022
        U
        Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
        Recruiting
        • Chronic Myeloid Leukemia
        • +2 more
        • Patient Reported Outcome Measure (PROM)
        • +2 more
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        2022-02-08
        Feb 8, 2022
        B
        Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
        Recruiting
        • Chronic Myeloid Leukemia
        • +2 more
        • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
        • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
        • Houston, Texas
        • +3 more
        2022-01-25
        Jan 25, 2022
        U
        Frontline Asciminib Combination in Chronic Phase CML
        Recruiting
        • Chronic Myeloid Leukemia
        • Aachen, Germany
        • +22 more
        2022-01-20
        Jan 20, 2022